Freenome has announced a strategic agreement with Roche aimed at commercialising its cancer screening technology outside the US. Exceeding $200m, the deal grants Roche exclusive rights to assemble ...
SUNNYVALE, Calif.--(BUSINESS WIRE)--ARK Diagnostics, Inc. (“ARK”), and Roche Diagnostics signed a letter of intent to negotiate a collaboration agreement that would grant Roche distribution and ...
Roche ($RHHBY) is not wasting any time after sealing its $1.2 billion deal for Foundation Medicine ($FMI), charging full speed ahead with the companies' planned ...
Roche has named the next CEO for its diagnostics efforts, as its prior division chief, Thomas Schinecker, is waiting in the wings to head up the Big Pharma overall starting next March. Matt Sause is ...
Jill German, head of Roche Tissue Diagnostics in Oro Valley and Marana, is retiring on Dec. 5, she announced Nov. 12.
Formation of strategic alliance designed to help accelerate advancement of new methods in molecular diagnostics testing and personalized predictive treatment Established in 2002, Roche's MCOE program ...
Roche will leverage Signature's unique expertise in both biobanks and NGS assays to develop novel diagnostics for cancer patients "Biobanks play an important role in uncovering the cause or origin of ...
As the leader in medical diagnostics, Roche (OTC: RHHB.F) acted quickly to deliver valuable COVID-19 screening tests to the marketplace. Assisted by COVID-related sales, its diagnostics division is ...
Roche Holdings has been making small acquisitions to gradually bolster its diagnostics portfolio, which constitutes roughly 15% of the company’s value according to our estimates. The industry’s ...
According to DataM Intelligence AUSTIN, Texas and TOKYO, Nov. 18, 2025 /PRNewswire/ -- DataM Intelligence announces the latest insights into the rapidly transforming Oncology Molecular Diagnostics ...
ZURICH (Reuters) - Surging demand globally for COVID-19 tests boosted third quarter revenues at Swiss drug company Roche's diagnostics business, helping to offset declining drug sales and keeping the ...